Point: steady progress and current challenges in clinical islet transplantation.
作者信息
Mineo Davide, Pileggi Antonello, Alejandro Rodolfo, Ricordi Camillo
出版信息
Diabetes Care. 2009 Aug;32(8):1563-9. doi: 10.2337/dc09-0490.
Abstract
摘要
相似文献
1
Point: steady progress and current challenges in clinical islet transplantation.要点：临床胰岛移植的稳步进展与当前挑战
Diabetes Care. 2009 Aug;32(8):1563-9. doi: 10.2337/dc09-0490.
2
Prediction of clinical outcome in islet allotransplantation.胰岛同种异体移植临床结局的预测
Diabetes Care. 2007 Feb;30(2):410-7. doi: 10.2337/dc06-1233.
3
Beta-cell therapies for type 1 diabetes: Transplants and bionics.1 型糖尿病的β细胞治疗：移植和仿生学。
Cleve Clin J Med. 2018 Dec;85(12):931-937. doi: 10.3949/ccjm.85a.17088.
4
Beta-cell replacement therapy (pancreas and islet transplantation) for treatment of diabetes mellitus: an integrated approach.用于治疗糖尿病的β细胞替代疗法（胰腺和胰岛移植）：一种综合方法。
Transplant Proc. 2004 Jul-Aug;36(6):1697-9. doi: 10.1016/j.transproceed.2004.06.069.
5
Cell replacement in type 1 diabetes mellitus.
J Pediatr Endocrinol Metab. 2005 Dec;18 Suppl 1:1157-61. doi: 10.1515/jpem.2005.18.s1.1157.
6
Beta-Cell Replacement: Pancreas and Islet Cell Transplantation.β细胞替代：胰腺与胰岛细胞移植
Endocr Dev. 2016;31:146-62. doi: 10.1159/000439412. Epub 2016 Jan 19.
7
Cell therapy for type 1 diabetes.1型糖尿病的细胞疗法。
QJM. 2014 Apr;107(4):253-9. doi: 10.1093/qjmed/hcu025. Epub 2014 Jan 29.
8
Cell-based therapy of diabetes: what are the new sources of beta cells?基于细胞的糖尿病治疗：新的β细胞来源有哪些？
Diabetes Metab. 2011 Nov;37(5):371-5. doi: 10.1016/j.diabet.2011.05.007. Epub 2011 Jul 21.
9
Current advances and travails in islet transplantation.胰岛移植的当前进展与困境
Diabetes. 2009 Oct;58(10):2175-84. doi: 10.2337/db09-0476.
10
Monitoring of beta cell replacement outcomes.β细胞替代治疗效果的监测。
Panminerva Med. 2016 Mar;58(1):59-71. Epub 2016 Jan 13.
引用本文的文献
1
Delivery of therapeutic agents and cells to pancreatic islets: Towards a new era in the treatment of diabetes.治疗剂和细胞向胰岛的递送：糖尿病治疗的新时代。
Mol Aspects Med. 2022 Feb;83:101063. doi: 10.1016/j.mam.2021.101063. Epub 2021 Dec 24.
2
Extracellular HMGB1 exacerbates autoimmune progression and recurrence of type 1 diabetes by impairing regulatory T cell stability.细胞外 HMGB1 通过损害调节性 T 细胞的稳定性，加剧自身免疫性进展和 1 型糖尿病的复发。
Diabetologia. 2020 May;63(5):987-1001. doi: 10.1007/s00125-020-05105-8. Epub 2020 Feb 19.
3
25 YEARS OF THE RICORDI AUTOMATED METHOD FOR ISLET ISOLATION.胰岛分离的里科尔迪自动化方法应用25年
CellR4 Repair Replace Regen Reprogram. 2013;1(1).
4
Sustained exenatide delivery via intracapsular microspheres for improved survival and function of microencapsulated porcine islets.通过囊内微球持续递送 exenatide，改善微囊化猪胰岛的存活和功能。
Drug Deliv Transl Res. 2018 Jun;8(3):857-862. doi: 10.1007/s13346-018-0484-x.
5
Repression of COUP-TFI Improves Bone Marrow-Derived Mesenchymal Stem Cell Differentiation into Insulin-Producing Cells.COUP-TFI的抑制作用可促进骨髓间充质干细胞向胰岛素分泌细胞的分化。
Mol Ther Nucleic Acids. 2017 Sep 15;8:220-231. doi: 10.1016/j.omtn.2017.06.016. Epub 2017 Jun 23.
6
Coronary artery calcium may stabilize following islet cell transplantation in patients with type 1 diabetes.1型糖尿病患者胰岛细胞移植后，冠状动脉钙化可能会稳定下来。
Clin Transplant. 2017 Oct;31(10). doi: 10.1111/ctr.13059. Epub 2017 Aug 19.
7
Use of additives, scaffolds and extracellular matrix components for improvement of human pancreatic islet outcomes in vitro: A systematic review.添加剂、支架和细胞外基质成分在体外改善人胰岛结果中的应用：一项系统综述。
Islets. 2017 Sep 3;9(5):73-86. doi: 10.1080/19382014.2017.1335842. Epub 2017 Jul 5.
8
Validation of Islet Transport From a Geographically Distant Isolation Center Enabling Equitable Access and National Health Service Funding of a Clinical Islet Transplant Program for England.来自地理上遥远的分离中心的胰岛转运的验证，以实现公平获取并为英格兰的临床胰岛移植项目提供国民医疗服务体系资金支持。
Cell Med. 2011 Dec 9;2(3):97-104. doi: 10.3727/215517911X617905. eCollection 2012.
9
Comprehensive Analysis of a Vibrio parahaemolyticus Strain Extracellular Serine Protease VpSP37.副溶血性弧菌菌株胞外丝氨酸蛋白酶VpSP37的综合分析
PLoS One. 2015 Jul 10;10(7):e0126349. doi: 10.1371/journal.pone.0126349. eCollection 2015.
10
Re-engineering islet cell transplantation.胰岛细胞移植的重新设计。
Pharmacol Res. 2015 Aug;98:76-85. doi: 10.1016/j.phrs.2015.02.010. Epub 2015 Mar 23.
本文引用的文献
1
Primary graft function, metabolic control, and graft survival after islet transplantation.胰岛移植后的原发性移植物功能、代谢控制及移植物存活情况。
Diabetes Care. 2009 Aug;32(8):1473-8. doi: 10.2337/dc08-1685.
2
Early metabolic markers of islet allograft dysfunction.胰岛移植功能障碍的早期代谢标志物。
Transplantation. 2009 Mar 15;87(5):689-97. doi: 10.1097/TP.0b013e318195c249.
3
Stable renal function after islet transplantation: importance of patient selection and aggressive clinical management.胰岛移植后稳定的肾功能：患者选择及积极临床管理的重要性
Transplantation. 2009 Mar 15;87(5):681-8. doi: 10.1097/TP.0b013e31819279a8.
4
Hematopoietic cell transplantation for tolerance induction: animal models to clinical trials.用于诱导耐受的造血细胞移植：从动物模型到临床试验
Transplantation. 2009 Feb 15;87(3):309-16. doi: 10.1097/TP.0b013e31819535c2.
5
Standards of medical care in diabetes--2009.《糖尿病医疗护理标准——2009》
Diabetes Care. 2009 Jan;32 Suppl 1(Suppl 1):S13-61. doi: 10.2337/dc09-S013.
6
2008 Update from the Collaborative Islet Transplant Registry.来自协作胰岛移植登记处的2008年更新
Transplantation. 2008 Dec 27;86(12):1783-8. doi: 10.1097/TP.0b013e3181913f6a.
7
A multi-year analysis of islet transplantation compared with intensive medical therapy on progression of complications in type 1 diabetes.一项关于胰岛移植与强化药物治疗对1型糖尿病并发症进展影响的多年分析。
Transplantation. 2008 Dec 27;86(12):1762-6. doi: 10.1097/TP.0b013e318190b052.
8
Islet transplantation with alemtuzumab induction and calcineurin-free maintenance immunosuppression results in improved short- and long-term outcomes.使用阿仑单抗诱导和无钙调神经磷酸酶维持免疫抑制的胰岛移植可改善短期和长期预后。
Transplantation. 2008 Dec 27;86(12):1695-701. doi: 10.1097/TP.0b013e31819025e5.
9
Long-term insulin independence and improvement in insulin secretion after supplemental islet infusion under exenatide and etanercept.在艾塞那肽和依那西普作用下，补充胰岛输注后实现长期胰岛素自主分泌并改善胰岛素分泌。
Transplantation. 2008 Dec 27;86(12):1658-65. doi: 10.1097/TP.0b013e31818fe448.
10
Improved long-term health-related quality of life after islet transplantation.胰岛移植后长期健康相关生活质量得到改善。
Transplantation. 2008 Nov 15;86(9):1161-7. doi: 10.1097/TP.0b013e31818a7f45.
Zotero 插件